SEC Form 4 · accession 0001140361-18-018493
BLONDER TONGUE LABORATORIES INC · BDR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen K Necessary
Director
Period of report
Apr 4, 2018
Accepted (ET)
Apr 13, 2018 · 1:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001000683
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2,F3 | $1.195 | Apr 4, 2018 | A | 18,630 | A | — | Apr 4, 2028 | Common Stock par value $0.001 | 18,630 | 18,630 | D |
Explanation of responses
- F1The stock option was granted under the 2016 Director Equity Incentive Plan.
- F2The exercise price equals the fair market value (equal to the average of the high and low selling prices as reported on the NYSE American) of the common stock on the grant date.
- F3The stock option vests on the first anniversary of the grant date.